Imagen de portada del programa Sarcoma Stories

Sarcoma Stories

Podcast de Sarcoma Foundation of America

inglés

Negocios

Empieza 7 días de prueba

$99 / mes después de la prueba.Cancela cuando quieras.

  • 20 horas de audiolibros al mes
  • Podcasts solo en Podimo
  • Podcast gratuitos
Prueba gratis

Acerca de Sarcoma Stories

We're excited to announce, "Sarcoma Stories" a new podcast from SFA.Sarcoma Stories is the only podcast highlighting the journey and experiences of people living and surviving sarcoma. Each episode will feature a guest sharing their sarcoma journey, resources they found valuable and more.Search Sarcoma Stories on your favorite podcast platform and be sure to follow to get updates on our latest episodes.We will also have a post episode discussion on our new facebook group. Join Now: https://www.facebook.com/groups/512452631597704

Todos los episodios

26 episodios

episode Gianna Cericola artwork

Gianna Cericola

On this episode, we speak with Gianna Cericola, a survivor of Desmoplastic Small Round Cell Tumor (DSRCT for short). After two long years, she rang the bell signifying the end of active treatment just two weeks before we recorded this episode. We feel so lucky to be able to sit down with her at this pivotal moment of transition. Gianna opens up about what being done with treatment actually means, and why the end of treatment isn’t the end of a cancer diagnosis. She shares about how she’s relied on self-advocacy, not only to receive a diagnosis but to navigate treatment and conversations with her medical team. As an adolescent young adult, Gianna talks about continuing to live her life through her diagnosis - including getting engaged during treatment and thinking about surrogacy to one day build her family - and why it can be difficult to plan for the future. This episode is full of raw and honest insight into Gianna’s experience, and we are so grateful for the time she took to share with us. We also wanted to note and give insight to a conversation we have about Gianna’s subtype being classified as ultra-rare. Sarcoma is a rare cancer to begin with, but within the numerous subtypes of sarcoma, there are some, like DSRCT, that are considered “ultra-rare” - defined as subtypes with an annual incidence of 1 or fewer cases per million people. Thank you Gianna for giving voice to the experience of being diagnosed with an ultra-rare subtype. Subtype Page: https://curesarcoma.org/sarcoma-subtypes/desmoplastic-small-round-cell-tumor/ [https://curesarcoma.org/sarcoma-subtypes/desmoplastic-small-round-cell-tumor/] Discussion Guide: https://curesarcoma.org/sfa-launches-sarcoma-diagnosis-and-treatment-discussion-guide/ [https://curesarcoma.org/sfa-launches-sarcoma-diagnosis-and-treatment-discussion-guide/] Sarcoma Stories FB Group: https://www.facebook.com/groups/512452631597704 [https://www.facebook.com/groups/512452631597704] Connect with Gianna: Gianna’s DSRCT Group: https://ig.me/j/Abb-dS58-Ff-DnKH/ [https://ig.me/j/Abb-dS58-Ff-DnKH/] Instagram: @gianna.cericola https://www.instagram.com/gianna.cericola/ [https://www.instagram.com/gianna.cericola/] TikTok: https://www.tiktok.com/@gianna.cericola [https://www.tiktok.com/@gianna.cericola]

20 de may de 2026 - 44 min
episode Tasha Nathan artwork

Tasha Nathan

On today’s episode we’re sharing the sarcoma story of one of our Sarcoma Stories hosts, Tasha. Tasha has been hosting Sarcoma Stories since its inception in November 2024 and she’s now sharing her story about her Embryonal Rhabdomyosarcoma diagnosis. We also talk about some of the transitions happening at SFA with Tasha’s role as she embarks on a new endeavor, starting her program - Move Anyway - while welcoming Katie Wintergerst to the podcast as co-host. Let’s dive in! Subtype Page: https://curesarcoma.org/sarcoma-subtypes/embryonal-rhabdomyosarcoma/ [https://curesarcoma.org/sarcoma-subtypes/embryonal-rhabdomyosarcoma/] Connect with Tasha: IG @tashanathan_ [https://www.instagram.com/tashanathan_/] @moveanyway_ [https://www.instagram.com/moveanyway_/] Email: hello@move-anyway.com [hello@move-anyway.com] Move-anyway.com [http://Move-anyway.com]

6 de may de 2026 - 56 min
episode Pan Pantziarka artwork

Pan Pantziarka

On this episode, we speak with SFA Director of Europe’s Strategy and Engagement, Pan Pantziarka. While he is an incredible staff member at SFA who supports SFA’s global work, he also has a sarcoma story of his own as a care partner to his son, George. After George was diagnosed with three different primary cancers and passed in 2011, Pan quit his job in the corporate sector and found work in oncology. He is committed to making a difference using everything he can - scientific training, advocacy, and demand for change. He speaks to us today about rare cancer predispositions, such as Li Fraumeni Syndrome, the story of George and his mother, why knowledge is power, and where he finds hope. We are so lucky to not only have this conversation with Pan, but to have him on the team at SFA, striving for answers for sarcoma patients and their families. Thank you Pan, for all you do for the sarcoma community. Subtype Page: https://curesarcoma.org/sarcoma-subtypes/osteosarcoma/ [https://curesarcoma.org/sarcoma-subtypes/osteosarcoma/] Sarcoma Patient Pathways Survey: https://curesarcoma.org/get-involved/sarcoma-patient-experience-survey/ [https://curesarcoma.org/get-involved/sarcoma-patient-experience-survey/] Discussion Guide: https://curesarcoma.org/sfa-launches-sarcoma-diagnosis-and-treatment-discussion-guide/ [https://curesarcoma.org/sfa-launches-sarcoma-diagnosis-and-treatment-discussion-guide/] Sarcoma Stories FB Group: https://www.facebook.com/groups/512452631597704 [https://www.facebook.com/groups/512452631597704]

23 de abr de 2026 - 56 min
episode Kate & Kristen artwork

Kate & Kristen

In this episode, we sit down with Kate DeForge, who was diagnosed with undifferentiated pleomorphic sarcoma as a young adult. Kate opens up about what it’s been like navigating young adulthood with sarcoma, and shares the mindset and philosophy that have shaped how she lives her life since her diagnosis. We’re also joined by Kate’s sister, Kristen, who offers her personal perspective on being on the sarcoma journey with a sibling. She reflects on her role in Kate’s care and how she helps bring a sense of normalcy to everyday life. It’s immediately clear that Kate and Kristen are a dynamic duo. They balance one another, communicate with the unspoken understanding that only siblings share, and together tell a powerful, honest story of how sarcoma is truly a family disease. Thank you, Kate and Kristen, for joining us and sharing your journey. Subtype Page: https://curesarcoma.org/sarcoma-subtypes/ewing-sarcoma/ [https://curesarcoma.org/sarcoma-subtypes/ewing-sarcoma/] Sarcoma Patient Pathways Survey: https://curesarcoma.org/get-involved/sarcoma-patient-experience-survey/ [https://curesarcoma.org/get-involved/sarcoma-patient-experience-survey/] Discussion Guide: https://curesarcoma.org/sfa-launches-sarcoma-diagnosis-and-treatment-discussion-guide/ [https://curesarcoma.org/sfa-launches-sarcoma-diagnosis-and-treatment-discussion-guide/] Sarcoma Stories FB Group: https://www.facebook.com/groups/512452631597704 [https://www.facebook.com/groups/512452631597704] Connect with Kate: Kate IG: @blueforkate https://www.instagram.com/blueforkate/ [https://www.instagram.com/blueforkate/]

2 de abr de 2026 - 1 h 3 min
episode Simone Cheatham artwork

Simone Cheatham

On this episode, we’re joined by Simone Cheatham, a member of the Race to Cure Sarcoma Chicago Committee. Simone became actively involved after her late father, Hardin—lovingly referred to as “Dad” throughout this episode—was diagnosed with sarcoma. Hardin’s journey with sarcoma was unique. His sarcoma diagnosis came shortly after he had already been diagnosed with breast cancer, leading Simone and her family into a complex and uncertain path toward understanding the disease and deciding how best to move forward with treatment. Simone shares what it was like to support her father as a caregiver alongside her mother, offering a deeply personal perspective on navigating a rare cancer diagnosis. Shortly after her father’s diagnosis, Simone’s experience took another unexpected turn when she herself was diagnosed with Hodgkin’s lymphoma. Simone reflects on the stark differences she observed between her own treatment options and those available to her father, and she speaks passionately about why advocacy and research in the sarcoma space are so critical. Simone, thank you for being such a powerful and committed voice in the sarcoma and cancer community, and for sharing Dad’s story with us. Let’s dive in. Sarcoma Patient Pathways Survey [https://curesarcoma.org/get-involved/sarcoma-patient-experience-survey/] Discussion Guide [https://curesarcoma.org/sfa-launches-sarcoma-diagnosis-and-treatment-discussion-guide/] Sarcoma Stories FB Group [https://www.facebook.com/groups/512452631597704] Connect with Simone: Instagram: @_simonemichelle_ Email: simone.m.cheatham@gmail.com LinkedIn: https://www.linkedin.com/in/simone-cheatham/ [https://www.linkedin.com/in/simone-cheatham/]

5 de mar de 2026 - 58 min
Muy buenos Podcasts , entretenido y con historias educativas y divertidas depende de lo que cada uno busque. Yo lo suelo usar en el trabajo ya que estoy muchas horas y necesito cancelar el ruido de al rededor , Auriculares y a disfrutar ..!!
Muy buenos Podcasts , entretenido y con historias educativas y divertidas depende de lo que cada uno busque. Yo lo suelo usar en el trabajo ya que estoy muchas horas y necesito cancelar el ruido de al rededor , Auriculares y a disfrutar ..!!
Fantástica aplicación. Yo solo uso los podcast. Por un precio módico los tienes variados y cada vez más.
Me encanta la app, concentra los mejores podcast y bueno ya era ora de pagarles a todos estos creadores de contenido

Elige tu suscripción

Más populares

Premium

20 horas de audiolibros

  • Podcasts solo en Podimo

  • Disfruta los shows de Podimo sin anuncios

  • Cancela cuando quieras

Empieza 7 días de prueba
Después $99 / mes

Prueba gratis

Sólo en Podimo

Audiolibros populares

Prueba gratis

Empieza 7 días de prueba. $99 / mes después de la prueba. Cancela cuando quieras.